The Procter & Gamble Company (PG)[Tv]

Key Developments

• Procter & Gamble announced a $3.8 billion all-cash acquisition of Thorne, marking its most significant strategic pivot in decades toward the high-growth wellness and longevity space—a transformative move aimed at capturing younger, health-conscious consumers through scientific credibility and digital personalization.
• PG issued updated fiscal 2027 guidance revealing $1 billion in after-tax cost headwinds from raw materials, energy, transportation, and interest rates—equivalent to a $0.56 EPS drag—while reporting flat organic sales driven solely by pricing, not volume, signaling deep structural demand weakness.
• The company confirmed a planned reduction of up to 7,000 non-manufacturing roles, a necessary but high-risk restructuring that threatens long-term innovation capacity and brand continuity, raising red flags about the sustainability of its competitive edge.
• HSBC downgraded Procter & Gamble to “Hold” from “Buy”, citing weak execution of reinvestment strategy, eroding pricing power, and stagnant volume growth—a pivotal shift in analyst sentiment that adds urgency to the upcoming earnings report.
• PG announced its 70th consecutive annual dividend increase, raising its quarterly payout to $1.0885 per share—a reaffirmation of its Dividend King status—as it maintains aggressive capital returns despite mounting growth and valuation concerns.